BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20226850)

  • 21. [A study on cell malignant transformation caused by dihydroxyglyoxime].
    Shen J; Jiang Y; Zhang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Nov; 31(6):346-8. PubMed ID: 9863068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of sensitivity to arsenic compounds between a Bhas 42 cell transformation assay and a BALB/c 3T3 cell transformation assay.
    Muramatsu D; Sasaki K; Kuroda S; Hayashi K; Tanaka N; Sakai A
    Mutat Res; 2009 Apr; 675(1-2):66-70. PubMed ID: 19386250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of transformed foci and induction of prostaglandins in Balb/c 3T3 cells by palytoxin: in vitro model reproduces carcinogenic responses in animal models regarding the inhibitory effect of indomethacin and reversal of indomethacin's effect by exogenous prostaglandins.
    Miura D; Kobayashi M; Kakiuchi S; Kasahara Y; Kondo S
    Toxicol Sci; 2006 Jan; 89(1):154-63. PubMed ID: 16192471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
    Kirkland D; Aardema M; Müller L; Makoto H
    Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone [MX] shows initiating and promoting activities in a two-stage BALB/c 3T3 cell transformation assay.
    Nakajima M; Shimada S; Nagai M; Mizuhashi F; Sugiyama C; Masuda S; Hayashi M; Kinae N
    Mutagenesis; 2005 Sep; 20(5):375-9. PubMed ID: 16081471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
    Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
    Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemical-induced transformation in BALB/c-3T3 cells: relationship between in vitro transformation and cytotoxicity, carcinogenesis, and genotoxicity.
    Matthews EJ
    Prog Clin Biol Res; 1990; 340D():229-38. PubMed ID: 2371296
    [No Abstract]   [Full Text] [Related]  

  • 31. Malignant transformation of BALB/3T3 cells by residue organic mixtures from drinking water.
    Lang DR; Kurzepa H; Cole MS; Loper JC
    J Environ Pathol Toxicol; 1980 Aug; 4(1):41-54. PubMed ID: 7441123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of human cell models for assessing the carcinogenic potential of chemicals.
    Pang Y; Li W; Ma R; Ji W; Wang Q; Li D; Xiao Y; Wei Q; Lai Y; Yang P; Chen L; Tang S; Lin Y; Zhuang Z; Zheng Y; Chen W
    Toxicol Appl Pharmacol; 2008 Nov; 232(3):478-86. PubMed ID: 18778725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphological transformation induced by multiwall carbon nanotubes on Balb/3T3 cell model as an in vitro end point of carcinogenic potential.
    Ponti J; Broggi F; Mariani V; De Marzi L; Colognato R; Marmorato P; Gioria S; Gilliland D; Pascual Garcìa C; Meschini S; Stringaro A; Molinari A; Rauscher H; Rossi F
    Nanotoxicology; 2013 Mar; 7(2):221-33. PubMed ID: 22279961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recommended protocol for the Syrian hamster embryo (SHE) cell transformation assay.
    Maire MA; Pant K; Phrakonkham P; Poth A; Schwind KR; Rast C; Bruce SW; Sly JE; Bohnenberger S; Kunkelmann T; Schulz M; Vasseur P
    Mutat Res; 2012 Apr; 744(1):76-81. PubMed ID: 22198328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic fate of ultratrace levels of GeCl(4) in the rat and in vitro studies on its basal cytotoxicity and carcinogenic potential in Balb/3T3 and HaCaT cell linesdagger.
    Sabbioni E; Fortaner S; Bosisio S; Farina M; Del Torchio R; Edel J; Fischbach M
    J Appl Toxicol; 2010 Jan; 30(1):34-41. PubMed ID: 19757410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The transgenic mouse assay as an alternative test method for regulatory carcinogenicity studies--implications for REACH.
    Wells MY; Williams ES
    Regul Toxicol Pharmacol; 2009 Mar; 53(2):150-5. PubMed ID: 19126422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Technical modification of the Balb/c 3T3 cell transformation assay: the use of serum-reduced medium to optimise the practicability of the protocol.
    Hayashi K; Sasaki K; Asada S; Tsuchiya T; Hayashi M; Yoshimura I; Tanaka N; Umeda M
    Altern Lab Anim; 2008 Dec; 36(6):653-65. PubMed ID: 19154092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
    Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.